CHRISTOPHER MILLS

Insider Reports History

Location
London, United Kingdom
Signature
/s/ Katie Kazem, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CHRISTOPHER MILLS:

Company Role Class Num Shares Value Price $ Report Date Ownership
Renalytix plc Director, 10%+ Owner Ordinary Shares 6,458,582 $1,614,646 $0.2500 01 Jul 2023 By North Atlantic Smaller Companies Investment Trust plc
Renalytix plc Director, 10%+ Owner Ordinary Shares 2,812,794 $703,199 $0.2500 01 Jul 2023 By Oryx International Growth Fund Limited
Renalytix plc Director, 10%+ Owner Ordinary Shares 801,124 $200,281 $0.2500 01 Jul 2023 By Harwood Capital LLP
Renalytix plc Director, 10%+ Owner Employee Stock Option (right to buy) 95,000 20 Nov 2023 Direct

Insider Reports Filed by CHRISTOPHER MILLS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNLXY Renalytix plc 20 Nov 2023 1 $0 4 Director, 10%+ Owner 22 Nov 2023, 16:27
RNLXY Renalytix plc 01 Jul 2023 0 $0 3 Director, 10%+ Owner 03 Jul 2023, 16:23